The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
High-dose methotrexate, temozolomide, and intrathecal liposomal cytarabine (HD-MTX-TMZ-IT LC), without radiotherapy for central nervous system (CNS) lymphoma.
L. Falchi
No relevant relationships to disclose
M. Gunnellini
No relevant relationships to disclose
L. Ferranti
No relevant relationships to disclose
I. Angeletti
No relevant relationships to disclose
A. M. Liberati
No relevant relationships to disclose